Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mai Hazekawa

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|August 20, 2020
Developing a Model for a siRNA Delivery System by Cancer Implantation into Zebrafish CirculationYasuhito Shimada, Mai Hazekawa
Anticancer Research|August 1, 2025
Application of Nucleic Acid Medicine Using Autologous Serum-derived Small Extracellular Vesicles for Cancer MetastasisMai Hazekawa, Takuya Nishinakagawa, Daisuke Ishibashi
Chemical & Pharmaceutical Bulletin|April 7, 2011
Influence of swallowing Aids on the adsorption and palatability of Kremezin®Miyako Yoshida, Mai Hazekawa, Tamami Haraguchi, et al.
Chemical & Pharmaceutical Bulletin|May 3, 2011
Synergistic effects of sour taste and low temperature in suppressing the bitterness of Aminoleban® ENTamami Haraguchi, Miyako Yoshida, Mai Hazekawa, et al.
Chemical & Pharmaceutical Bulletin|April 23, 2010
Bitterness suppression of the Kampo medicine 'Orengedokuto' using flavoured jelliesMiyako Yoshida, Emi Tokuyama, Mai Hazekawa, et al.
Journal of Pharmacological Sciences|February 27, 2019
Glypican-3 gene silencing for ovarian cancer using siRNA-PLGA hybrid micelles in a murine peritoneal dissemination modelMai Hazekawa, Takuya Nishinakagawa, Tomoyo Kawakubo-Yasukochi, et al.
Pharmaceutics|April 23, 2022
Development of an Organ-Directed Exosome-Based siRNA-Carrier Derived from Autologous Serum for Lung Metastases and Testing in the B16/BL6 Spontaneous Lung Metastasis ModelMai Hazekawa, Takuya Nishinakagawa, Masato Hosokawa, et al.
Drug Development and Industrial Pharmacy|September 9, 2014
Evaluation of the palatabilities in 10 different famotidine orally disintegrating tablets by combination of disintegration device and taste sensorMiyako Yoshida, Mai Hazekawa, Tamami Haraguchi, et al.
Molecular Medicine Reports|February 3, 2023
RCAS1 increases cell morphological changes in murine fibroblasts by reducing p38 phosphorylationTakuya Nishinakagawa, Mai Hazekawa, Masato Hosokawa, et al.
Experimental and Therapeutic Medicine|September 27, 2019
Evaluation of IC<sub>50</sub> levels immediately after treatment with anticancer reagents using a real-time cell monitoring deviceMai Hazekawa, Takuya Nishinakagawa, Tomoyo Kawakubo-Yasukochi, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Methods in Molecular Biology (Clifton, N.J.)|August 20, 2020
Developing a Model for a siRNA Delivery System by Cancer Implantation into Zebrafish CirculationYasuhito Shimada, Mai Hazekawa
Anticancer Research|August 1, 2025
Application of Nucleic Acid Medicine Using Autologous Serum-derived Small Extracellular Vesicles for Cancer MetastasisMai Hazekawa, Takuya Nishinakagawa, Daisuke Ishibashi
Chemical & Pharmaceutical Bulletin|April 7, 2011
Influence of swallowing Aids on the adsorption and palatability of Kremezin®Miyako Yoshida, Mai Hazekawa, Tamami Haraguchi, et al.
Chemical & Pharmaceutical Bulletin|May 3, 2011
Synergistic effects of sour taste and low temperature in suppressing the bitterness of Aminoleban® ENTamami Haraguchi, Miyako Yoshida, Mai Hazekawa, et al.
Chemical & Pharmaceutical Bulletin|April 23, 2010
Bitterness suppression of the Kampo medicine 'Orengedokuto' using flavoured jelliesMiyako Yoshida, Emi Tokuyama, Mai Hazekawa, et al.
Journal of Pharmacological Sciences|February 27, 2019
Glypican-3 gene silencing for ovarian cancer using siRNA-PLGA hybrid micelles in a murine peritoneal dissemination modelMai Hazekawa, Takuya Nishinakagawa, Tomoyo Kawakubo-Yasukochi, et al.
Pharmaceutics|April 23, 2022
Development of an Organ-Directed Exosome-Based siRNA-Carrier Derived from Autologous Serum for Lung Metastases and Testing in the B16/BL6 Spontaneous Lung Metastasis ModelMai Hazekawa, Takuya Nishinakagawa, Masato Hosokawa, et al.
Drug Development and Industrial Pharmacy|September 9, 2014
Evaluation of the palatabilities in 10 different famotidine orally disintegrating tablets by combination of disintegration device and taste sensorMiyako Yoshida, Mai Hazekawa, Tamami Haraguchi, et al.
Molecular Medicine Reports|February 3, 2023
RCAS1 increases cell morphological changes in murine fibroblasts by reducing p38 phosphorylationTakuya Nishinakagawa, Mai Hazekawa, Masato Hosokawa, et al.
Experimental and Therapeutic Medicine|September 27, 2019
Evaluation of IC<sub>50</sub> levels immediately after treatment with anticancer reagents using a real-time cell monitoring deviceMai Hazekawa, Takuya Nishinakagawa, Tomoyo Kawakubo-Yasukochi, et al.
Pageof 5